Oncolys BioPharma Inc. (TYO:4588)
Japan · Delayed Price · Currency is JPY 6,300.00
+370.00 (6.24%)
Oct 26, 2026, 3:30 PM JST
Oncolys BioPharma Market Cap
Oncolys BioPharma has a market cap or net worth of 185.76 billion as of October 26, 2026. It is the 9,208th most valuable company in the world and the 692nd biggest in Japan. Its market cap has increased by 951.48% in one year.
Market Cap
185.76B
Enterprise Value
183.37B
Revenue
28.55M
Global Rank
Country Rank
#692 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 6, 2013, Oncolys BioPharma's market cap has increased from 23.62B to 185.76B, an increase of 686.51%. That is a compound annual growth rate of 17.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 185.76B | 369.24% |
| Dec 30, 2025 | 39.59B | 207.33% |
| Dec 30, 2024 | 12.88B | 18.41% |
| Dec 29, 2023 | 10.88B | 19.14% |
| Dec 30, 2022 | 9.13B | -0.44% |
| Dec 30, 2021 | 9.17B | -58.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GNI Group | 187.37B |
| PeptiDream | 136.41B |
| Nxera Pharma | 124.55B |
| SanBio Company | 70.25B |
| Heartseed | 61.88B |
| Cuorips | 57.63B |
| 3-D Matrix | 46.33B |
| Healios K.K. | 36.60B |